Article
Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study.
Neuroscience letters - 15 Jun 2007
Brighina Laura, Okubadejo Njide U, Schneider Nicole K, Lesnick Timothy G, de Andrade Mariza, Cunningham Julie M, Farrer Matthew J, Lincoln Sarah J, Rocca Walter A, Maraganore Demetrius M
Abstract excerpt
Aggregation and fibrillization of the alpha-synuclein protein, which is the main component of Lewy bodies, may represent important processes in the pathogenesis of Parkinson's disease (PD). Several in vivo and in vitro studies suggest that beta-synuclein may be a natural negative regulator of alpha-synuclein aggregation and fibrillization. The goal of the present study was to investigate the association of two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
